PARP16 and cancer: Finally, we demonstrated that epigallocatechin-3-gallate (EGCG) was a potential inhibitor of PARP16, which suppressed the ER stress-induced phosphorylation of PERK and the transcription of UPR-related genes, leading to a dramatical increase of the cancer cells apoptosis under ER stress conditions.